AD mission in the U.K.

The U.K. government is responding to calls for a dementia therapy by 2025 by securing nearly £120 million ($205 million) from U.K.-based organizations for a series of research initiatives that span R&D from discovery to the clinic. Reaching the target might require international coordination to incentivize investors.

In the last few years, several governments have responded to the looming healthcare crisis in Alzheimer's disease (AD) by launching or joining public-private partnerships with pharmas, not-for-profit organizations and academic organizations (see "Dementia public-private partnerships")...